Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Hammarström

Lars-Göran Lennart Hammarström, Huddinge SE

Patent application numberDescriptionPublished
20080206233Heavy Chain And Single Domain Antibodies - The present invention relates to heavy chain immunoglobulins or fragments thereof of the VHH or VNAR type, or domain antibodies (dAbs) of the heavy or light chains of immunoglobulins or fragments thereof, suitable for use in the management of infections, in particular of the gastrointestinal tract. The present invention also relates to a delivery system comprising these heavy chain immunoglobulins or functional fragments thereof of the VHH or VNAR type, or domain antibodies (dAbs) of the heavy or light chains of immunoglobulins or fragments thereof, and hosts comprising expression vectors encoding for these heavy chain immunoglobulins or functional fragments thereof of the VHH or VNAR type, or domain antibodies (dAbs) of the heavy or light chains of immunoglobulins or fragments thereof. The invention also relates to food products and pharmaceutical preparations comprising the delivery system, and methods for the preparation of food products according to the invention.08-28-2008
20090226418Food Products Comprising Probiotic Micro-Organisms and Antibodies - The present invention relates to food products or pharmaceutical preparations comprising antibodies or antibody fragments which are active in the gut and probiotic micro-organisms independent from the antibodies or antibody fragments. In particular, the invention relates to a method for preparing food products and pharmaceutical preparations comprising the antibodies or antibody fragments and probiotic micro-organisms and the use of these products to deliver health benefits to humans.09-10-2009

Lars-Göran Lennart Hammarström, Huddinge SE

Patent application numberDescriptionPublished
20090226418Food Products Comprising Probiotic Micro-Organisms and Antibodies - The present invention relates to food products or pharmaceutical preparations comprising antibodies or antibody fragments which are active in the gut and probiotic micro-organisms independent from the antibodies or antibody fragments. In particular, the invention relates to a method for preparing food products and pharmaceutical preparations comprising the antibodies or antibody fragments and probiotic micro-organisms and the use of these products to deliver health benefits to humans.09-10-2009
20110123546Compositions Comprising Antibodies or Antibody Fragments - The present invention relates to food products or pharmaceutical preparations comprising a synergistic combination of at least two different antibodies or antibody fragments which are directed against a virus, preferably against rotavirus.05-26-2011

Lennart Hammarström, Huddinge SE

Patent application numberDescriptionPublished
20110311475MEANS AND METHOD FOR THE TREATMENT OF ANTIBODY DEFICIENCY DISEASES BASED ON IL-21 AND IL-21 VARIANTS - The present invention relates to an lnterleukin-21 (IL-21) variant which is capable of increasing the secretion of IgG and/or IgA antibodies in B cells and/or is capable of binding the IL-2 receptor complex and/or the IL-4 receptor complex, comprising stretches of amino acids of lnterleukin-4 (IL-4) or lnterleukin-2 (IL-2) in substitution of amino acids of IL-21. The present invention also relates to a pharmaceutical composition comprising IL-21 and/or an IL-21 variant and at least one compound selected from IgA inducing protein (IGIP), Syntenin-1, Galectin-1 and Galectin-3. The present invention further relates to a pharmaceutical composition for the treatment of a primary humoral immunodeficiency disease comprising IL-21 and/or an IL-21 variant and IL-4 and/or IL-2 and/or IGIP and/or Syntenin-1 and/or Galectin-1 and/or Galectin-3. Furthermore the present invention relates to a kit for the treatment of a primary humoral immunodeficiency disease, comprising IL-21 and/or an IL-21 variant and IL-4 and/or IL-2 and/or IGIP and/or Syntenin-1 and/or Galectin-1 and/or Galectin-3 and optionally at least one element selected from a stimulator of CD40 molecules, a ligand of the tumor necrosis superfamily, a polypeptide with human leukocyte interferon activity, a vaccine protein antigen; and a vaccine polysaccharide antigen.12-22-2011

Per, Jonas Hammarström, Linkoping SE

Patent application numberDescriptionPublished
20110311103 METHOD AND SYSTEM OF AUTOMATICALLY DETECTING OBJECTS IN FRONT OF A MOTOR VEHICLE - A method of automatically detecting objects in front of a motor vehicle comprises the steps of pre-storing template objects representing possible objects in front of the motor vehicle, detecting images from a region in front of the vehicle by a vehicle mounted imaging means, generating a processed image containing disparity or vehicle-to-scene distance information from the detected images, comparing the pre-stored template objects with corresponding regions-of-interest of the processed image, and generating a match result relating to the match between the processed image and the template objects. Each of the pre-stored template objects is a flat two-dimensional multi-pixel area of predetermined shape.12-22-2011